MTCR — Metacrine Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Annual balance sheet for Metacrine, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	C2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	33.9	73	55.7	96.2	76.4
Net Total Receivables	—	—	0.191	0.194	0.026
Prepaid Expenses
Total Other Current Assets
Total Current Assets	34.3	74.1	57.3	102	78.7
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.707	3.68	2.94	2.21	1.25
Other Long Term Assets
Total Assets	35	77.8	60.3	104	80
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.95	4.25	4.39	4.03	7.76
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	4.21	6.8	16.1	15	22.6
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	30.8	71	44.2	89.3	57.4
Total Liabilities & Shareholders' Equity	35	77.8	60.3	104	80
Total Common Shares Outstanding